Prednisolone

Last updated

Prednisolone
Prednisolone-2D-skeletal.svg
Prednisolone-from-xtal-3D-bs-17.png
Clinical data
Trade names Orapred, PediaPred, Millipred, others
Other names11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
AHFS/Drugs.com Monograph
MedlinePlus a615042
License data
Pregnancy
category
Routes of
administration 		By mouth, intravenous, topical, ophthalmic
Drug class Glucocorticoid
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
  • US: ℞-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Elimination half-life 2–3.5 hours [2] [3] [4]
Excretion urine
Identifiers
  • (11β)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.000.020 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C21H28O5
Molar mass 360.450 g·mol−1
3D model (JSmol)
  • O=C\1\C=C/[C@]4(/C(=C/1)CC[C@@H]2[C@@H]4[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@@H]23)C)C
  • InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 Yes check.svgY
  • Key:OIGNJSKKLXVSLS-VWUMJDOOSA-N Yes check.svgY
   (verify)

Prednisolone is a corticosteroid, a steroid hormone used to treat certain types of allergies, inflammatory conditions, autoimmune disorders, and cancers, electrolyte imbalances and skin conditions. [5] [6] Some of these conditions include adrenocortical insufficiency, high blood calcium, rheumatoid arthritis, dermatitis, eye inflammation, asthma, multiple sclerosis, and phimosis. [6] It can be taken by mouth, injected into a vein, used topically as a skin cream, or as eye drops. [7] [8] [6] It differs from the similarly named prednisone in having a hydroxyl at the 11th carbon instead of a ketone.

Contents

Common side effects with short-term use include nausea, difficulty concentrating, insomnia, increased appetite, and fatigue. [5] More severe side effects include psychiatric problems, which may occur in about 5% of people. [9] Common side effects with long-term use include bone loss, weakness, yeast infections, and easy bruising. [6] While short-term use in the later part of pregnancy is safe, long-term use or use in early pregnancy is occasionally associated with harm to the baby. [1] It is a glucocorticoid made from hydrocortisone (cortisol). [10]

Prednisolone was discovered and approved for medical use in 1955. [10] It is on the World Health Organization's List of Essential Medicines. [11] It is available as a generic drug. [6] In 2022, it was the 136th most commonly prescribed medication in the United States, with more than 4 million prescriptions. [12] [13]

Medical uses

When used in low doses, corticosteroids serve as an anti-inflammatory agent. At higher doses, they are considered as immunosuppressants. [14] Corticosteroids inhibit the inflammatory response to a variety of inciting agents and, it is presumed, delay or slow healing. [15] They inhibit edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation. [16]

Systemic use

Prednisolone is a corticosteroid drug with predominant glucocorticoid and low mineralocorticoid activity, making it useful for the treatment of a wide range of inflammatory and autoimmune conditions [17] such as asthma, [18] uveitis, pyoderma gangrenosum, rheumatoid arthritis, urticaria, [19] angioedema, [19] ulcerative colitis, pericarditis, temporal arteritis, Crohn's disease, Bell's palsy, multiple sclerosis, [20] cluster headaches, vasculitis, acute lymphoblastic leukemia, autoimmune hepatitis, [21] lupus, Kawasaki disease, [22] dermatomyositis, [7] post-myocardial infarction syndrome, [23] and sarcoidosis. [24]

Prednisolone can also be used for allergic reactions ranging from seasonal allergies to drug allergic reactions. [25]

Prednisolone can also be used as an immunosuppressant for organ transplants. [7] [26]

Prednisolone in lower doses can be used in cases of adrenal insufficiency due to Addison's disease. [27] [28]

Topical use

Ophthalmology

Conjunctivitis Conjuntivitis (RPS 03-06-2015).png
Conjunctivitis

Topical prednisolone is mainly used in the ophthalmic pathway as eye drops in numerous eye conditions, [29] including corneal injuries caused by chemicals, burns, and alien objects, inflammation of the eyes, mild to moderate non-infectious allergies, disorders of the eyelid, conjunctiva or sclera, ocular inflammation caused by operation and optic neuritis. [30] [31] Some side effects include glaucoma, blurred vision, eye discomfort, impaired recovery of injured site, scarring of the optic nerve, cataracts, and urticaria. [31] However, their prevalence is not known.

Prednisolone eye drops are contraindicated in individuals who develop hypersensitivity reactions against prednisolone, [29] or individuals with the current conditions, such as tuberculosis of the eye, shingles affecting the eye, raised intraocular pressure, and eye infection caused by fungus. [32]

Prednisolone acetate ophthalmic suspension (eye drops) is prepared as a sterile ophthalmic suspension and used to reduce swelling, redness, itching, and allergic reactions affecting the eye. [33] [8] [34] It has been explored as a treatment option for bacterial keratitis. [35]

Prednisolone eye drops are used in conjunctivitis caused by allergies and bacteria, marginal keratitis, uveitis, endophthalmitis, which is an infection of the eye involving the aqueous humor, Graves' ophthalmopathy, herpes zoster ocular infection, inflammation of the eye after surgery, and corneal injuries caused by chemicals, radiation, thermal burns, or penetration of foreign objects. [30] It is also used in the prevention of myringosclerosis, [36] herpes simplex stromal keratitis. [37] Topical prednisolone can also be used after procedures such as Laser Peripheral Iridotomy for patients with primary angle-closure suspects (PACS) to control inflammations. [38]

Ear drops

In addition, topical prednisolone can also be administered as ear drops. [39]

Pred Forte Ophthalmic Suspension (Prednisolone acetate ophthalmic suspension) [second right] 001 2019 05 27 Augenpflege.jpg
Pred Forte Ophthalmic Suspension (Prednisolone acetate ophthalmic suspension) [second right]
Examples of topical prednisolone Products
Eye dropsEar drops
Prednisolone sodium phosphate ophthalmic solution [29] Prednisolone sodium phosphate 0.5% eye/ ear drops [39]
Pred forte ophthalmic suspension (prednisolone acetate ophthalmic suspension) [33]
Suspension (prednisolone mild ophthalmic) [29]
Suspension (prednisolone acetate ophthalmic) [29]

Adverse effects

Adverse reactions from the use of prednisolone include: [40] [7]

Discontinuing prednisolone after long-term or high-dose use can lead to adrenal insufficiency. [41]

Pregnancy and breastfeeding

Although there are no major human studies of prednisolone use in pregnant women, studies in several animals show that it may cause birth defects including increased likelihood of cleft palate.

Prednisolone is found in the breast milk of mothers taking prednisolone. [41]

Local adverse effects in the eye

Cataract Cataract (28464844371).png
Cataract

When used topically on the eye, the following are potential side effects:

Pharmacology

Pharmacodynamics

As a glucocorticoid, the lipophilic structure of prednisolone allows for easy passage through the cell membrane where it then binds to its respective glucocorticoid receptor (GCR) located in the cytoplasm. Upon binding, the formation of the GC/GCR complex causes dissociation of chaperone proteins from the glucocorticoid receptor enabling the GC/GCR complex to translocate inside the nucleus. [45] This process occurs within 20 minutes of binding. Once inside the nucleus, the homodimer GC/GCR complex binds to specific DNA binding sites known as glucocorticoid response elements (GREs) resulting in gene expression or inhibition. Complex binding to positive GREs leads to the synthesis of anti-inflammatory proteins while binding to negative GREs blocks the transcription of inflammatory genes. [46] They inhibit the release of signals that promote inflammation such as nuclear factor-Kappa B (NF-κB), Activator protein 1 (AP-1), nuclear factor of activated T-cells (NFAT), and stimulate anti-inflammatory signals such as the interleukin-10 gene. [47] [14] All of them will collectively cause a sequence of events, including the inhibition of prostaglandin synthesis and additional inflammatory mediators. Glucocorticoids also inhibit neutrophil cell death and demargination. As well as phospholipase A2, which in turn lessens arachidonic acid derivative genesis. [48]

Pharmacokinetics

Prednisolone has a relatively short half-life, ranging 2–4 hours. It also has a large therapeutic window, considering the dosage required to produce a therapeutic effect is a few times higher than what the body naturally produces. [14]

Prednisolone is 70–90% plasma protein bound, it binds to proteins such as albumin. [14]

Both prednisolone phosphate and prednisolone acetate go through ester hydrolysis in the body to form prednisolone. It subsequently undergoes the usual metabolism of prednisolone. Concomitant use of prednisolone and strong CYP3A4 inhibitors such as ketoconazole is shown to cause a rise in plasma prednisolone concentrations by about 50% owing to a diminished clearance. [47]

Prednisolone predominantly undergoes kidney elimination and is excreted in the urine as sulphate and metabolites of glucuronide conjugate. [14]

Prednisone

Prednisone is a prodrug that is activated in the liver. When it enters the body, prednisone is triggered by the liver and body chemicals to turn into its active form, prednisolone. [49]

Chemistry

Prednisolone is a synthetic pregnane corticosteroid closely related to its cognate prednisone, having identical structure save for two fewer hydrogens near C11. It is also known as δ1-cortisol, δ1-hydrocortisone, 1,2-dehydrocortisol, or 1,2-dehydrohydrocortisone, as well as 11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione. [50] [51]

Interactions

Co-administration of prednisolone eye drops with ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) may perhaps exacerbate its effects, causing unwanted side effects such as toxicity.[ clarification needed ] The wound healing process may also be hindered. [52]

Drug interactions of prednisolone include other immunosuppressants like azathioprine or ciclosporin, antiplatelet drugs like clopidogrel, anticoagulants like dabigatran or warfarin, or NSAIDs such as aspirin, celecoxib, or ibuprofen. [53]

Contraindications

Special populations

Children

Prolonged use of prednisolone eye drops in children may lead to raised intraocular pressure. While this phenomenon is dose-dependent, it is shown to have a greater effect, especially in children under 6 years of age. [29]

Pregnancy and breastfeeding

Research on animal reproduction has indicated that there is a trace of teratogenicity when doses are reduced by 10 times the human recommended dose. [54] There is no sufficient information on human pregnancy at this moment. Use is only recommended when the potential benefits outweigh the potential risks for the pregnant mother and the fetus. [54]

Prednisolone when delivered systemically can be found in the mother's breast milk, however, there is no data provided for the extent of prednisolone found in the system after administering eye drops. [29] [54] However, the presence of corticosteroids is recorded when they are administered systemically, and it could affect the fetus' growth. [54] Therefore, the use of prednisolone during breastfeeding is not advocated. [54]

Society and culture

Dosage forms

Prednisolone is supplied as oral liquid, oral suspension, oral syrup, oral tablet, and oral disintegrating tablet. It may be a generic medication or supplied as brands Flo-Pred (prednisolone acetate oral suspension), [40] Millipred (oral tablets), [25] Orapred (prednisolone sodium phosphate oral dissolving tablets), [7] Pediapred (prednisolone sodium phosphate oral solution), [41] Veripred 20, Prelone, Hydeltra-T.B.A., Hydeltrasol, Key-Pred, Cotolone, Predicort, Medicort, Predcor, Bubbli-Pred, Omnipred (prednisolone acetate ophthalmic suspension), [8] Pred Mild, [34] Pred Forte, [33] and others. [55]

Athletics

As a glucocorticosteroid, unauthorized or ad hoc use of prednisolone during competition via oral, intravenous, intramuscular, or rectal routes is banned under World Anti-Doping Agency (WADA) anti-doping rules. [56]

Veterinary uses

Prednisolone is used in the treatment of inflammatory and allergic conditions in cats, dogs, horses, small mammals such as ferrets, birds, and reptiles. [57] [58] Its usage in treating inflammation, immune-mediated disease, Addison's disease, and neoplasia is often considered off-label use. Many drugs are commonly prescribed for off-label use in veterinary medicine." [59] Studies in ruminating species, such as alpacas, have shown that oral administration of the drug is associated with a reduced bioavailability compared to intravenous administration; however, levels that are therapeutic in other species can be achieved with oral administration in alpacas. [60]

It is used in a broad spectrum of diseases, for example, inflammation of scleral tissues, cornea, and conjunctiva in dogs. [57] In horses, prednisolone acetate suspensions are priorly used to treat inflammation in the middle layer of the eye, also known as anterior uveitis and equine recurrent uveitis (ERU), which is the leading cause of visual impairment in horses. [58] Prednisolone acetate eye drops are not to be used in other animals such as birds. [57]

Prednisolone acetate eye drops are also prescribed to dogs and cats to lessen swelling, redness, burning, and pain sensations after surgeries of the eye. [57]

Cats with conjunctivitis usually are required to avoid using ophthalmic preparations of corticosteroids and its derivatives. The most typical infections are caused by herpes virus. [58]

Related Research Articles

<span class="mw-page-title-main">Corticosteroid</span> Class of steroid hormones

Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Two main classes of corticosteroids, glucocorticoids and mineralocorticoids, are involved in a wide range of physiological processes, including stress response, immune response, and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.

<span class="mw-page-title-main">Dexamethasone</span> Corticosteroid medication

Dexamethasone is a fluorinated glucocorticoid medication used to treat rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive pulmonary disease (COPD), croup, brain swelling, eye pain following eye surgery, superior vena cava syndrome, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it may be used in combination with a mineralocorticoid medication such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be given by mouth, as an injection into a muscle, as an injection into a vein, as a topical cream or ointment for the skin or as a topical ophthalmic solution to the eye. The effects of dexamethasone are frequently seen within a day and last for about three days.

<span class="mw-page-title-main">Prednisone</span> Steroid medication

Prednisone is a glucocorticoid medication mostly used to suppress the immune system and decrease inflammation in conditions such as asthma, COPD, and rheumatologic diseases. It is also used to treat high blood calcium due to cancer and adrenal insufficiency along with other steroids. It is taken by mouth.

<span class="mw-page-title-main">Hydrocortisone</span> Glucocorticoid and Mineralocorticoid hormone Cortisol supplied as a medication

Hydrocortisone is the name for the hormone cortisol when supplied as a medication. It is a corticosteroid and works as an anti-inflammatory and by immune suppression. Uses include conditions such as adrenocortical insufficiency, adrenogenital syndrome, high blood calcium, thyroiditis, rheumatoid arthritis, dermatitis, asthma, and COPD. It is the treatment of choice for adrenocortical insufficiency. It can be given by mouth, topically, or by injection. Stopping treatment after long-term use should be done slowly.

<span class="mw-page-title-main">Glucocorticoid</span> Class of corticosteroids

Glucocorticoids are a class of corticosteroids, which are a class of steroid hormones. Glucocorticoids are corticosteroids that bind to the glucocorticoid receptor that is present in almost every vertebrate animal cell. The name "glucocorticoid" is a portmanteau and is composed from its role in regulation of glucose metabolism, synthesis in the adrenal cortex, and its steroidal structure.

<span class="mw-page-title-main">Triamcinolone</span> Steroid medication

Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD). It can be taken in various ways including by mouth, injection into a muscle, and inhalation.

<span class="mw-page-title-main">Methylprednisolone</span> Corticosteroid medication

Methylprednisolone is a synthetic glucocorticoid, primarily prescribed for its anti-inflammatory and immunosuppressive effects. It is either used at low doses for chronic illnesses or used concomitantly at high doses during acute flares. Methylprednisolone and its derivatives can be administered orally or parenterally.

<span class="mw-page-title-main">Fluticasone propionate</span> Medication

Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a glucocorticoid steroid medication. When inhaled it is used for the long term management of asthma and COPD. In the nose it is used for hay fever and nasal polyps. It can also be used for mouth ulcers. It works by decreasing inflammation.

<span class="mw-page-title-main">Triamcinolone acetonide</span> Medicinal chemical compound, steroid

Triamcinolone acetonide, sold under the brand name Kenalog among others, is a synthetic corticosteroid medication used topically to treat various skin conditions, to relieve the discomfort of mouth sores, and by injection into joints to treat various joint conditions. It is also injected into lesions to treat inflammation in some parts of the body, particularly the skin. In nasal spray form, it is used to treat allergic rhinitis. It is used for the treatment of macular edema associated with uveitis. It is a more potent derivative of triamcinolone, and is about eight times as potent as prednisone.

<span class="mw-page-title-main">Mometasone</span> Steroid medication

Mometasone, also known as mometasone furoate, is a steroid medication used to treat certain skin conditions, hay fever, and asthma. Specifically it is used to prevent rather than treat asthma attacks. It can be applied to the skin, inhaled, or used in the nose. Mometasone furoate, not mometasone, is used in medical products.

<span class="mw-page-title-main">Pemphigoid</span> Autoimmune blistering diseases

Pemphigoid is a group of rare autoimmune blistering diseases of the skin and mucous membranes. As its name indicates, pemphigoid is similar in general appearance to pemphigus, however unlike pemphigus, pemphigoid does not feature acantholysis, a loss of connections between skin cells.

<span class="mw-page-title-main">Sulfacetamide</span> Sulfonamide antibiotic

Sulfacetamide is a sulfonamide antibiotic commonly used in the treatment of bacterial infections, particularly those affecting the eyes and skin. It functions by inhibiting the synthesis of folic acid in bacteria, which is essential for their growth and reproduction, thereby exerting a bacteriostatic effect. Available in various forms, including eye drops, topical solutions, and creams, sulfacetamide is often prescribed for conditions such as conjunctivitis, seborrheic dermatitis, and acne vulgaris. Its efficacy, coupled with a relatively low risk of side effects, makes it a widely utilized agent in both ophthalmic and dermatologic care.

<span class="mw-page-title-main">Loteprednol</span> Pharmaceutical drug

Loteprednol is a topical corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax and Loterex.

<span class="mw-page-title-main">Deflazacort</span> Pharmaceutical drug

Deflazacort is a glucocorticoid belonging to acetonides or O-isopropylidene derivative. It is used as an anti-inflammatory and was patented in 1969 and approved for medical use in 1985. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication for Duchenne Muscular Dystrophy.

<span class="mw-page-title-main">Selective glucocorticoid receptor modulator</span> Class of experimental drugs

Selective glucocorticoid receptor modulators (SEGRMs) and selective glucocorticoid receptor agonists (SEGRAs) formerly known as dissociated glucocorticoid receptor agonists (DIGRAs) are a class of experimental drugs designed to share many of the desirable anti-inflammatory, immunosuppressive, or anticancer properties of classical glucocorticoid drugs but with fewer side effects such as skin atrophy. Although preclinical evidence on SEGRAMs’ anti-inflammatory effects are culminating, currently, the efficacy of these SEGRAMs on cancer are largely unknown.

<span class="mw-page-title-main">Fluticasone furoate</span> Corticosteroid

Fluticasone furoate, sold under the brand name Flonase Sensimist among others, is a corticosteroid for the treatment of non-allergic and allergic rhinitis administered by a nasal spray. It is also available as an inhaled corticosteroid to help prevent and control symptoms of asthma. It is derived from cortisol. Unlike fluticasone propionate, which is only approved for children four years and older, fluticasone furoate is approved in children as young as two years of age when used for allergies.

<span class="mw-page-title-main">Herpes simplex keratitis</span> Medical condition

Herpetic simplex keratitis is a form of keratitis caused by recurrent herpes simplex virus (HSV) infection in the cornea.

<span class="mw-page-title-main">Vamorolone</span> Chemical compound

Vamorolone, sold under the brand name Agamree, is a synthetic corticosteroid, which is used for the treatment of Duchenne muscular dystrophy. It is taken by mouth. It is a dual atypical glucocorticoid and antimineralocorticoid.

Prostaglandin inhibitors are drugs that inhibit the synthesis of prostaglandin in human body. There are various types of prostaglandins responsible for different physiological reactions such as maintaining the blood flow in stomach and kidney, regulating the contraction of involuntary muscles and blood vessels, and act as a mediator of inflammation and pain. Cyclooxygenase (COX) and Phospholipase A2 are the major enzymes involved in prostaglandin production, and they are the drug targets for prostaglandin inhibitors. There are mainly 2 classes of prostaglandin inhibitors, namely non- steroidal anti- inflammatory drugs (NSAIDs) and glucocorticoids. In the following sections, the medical uses, side effects, contraindications, toxicity and the pharmacology of these prostaglandin inhibitors will be discussed.

<span class="mw-page-title-main">Antiarthritics</span> Drug class

An antiarthritic is any drug used to relieve or prevent arthritic symptoms, such as joint pain or joint stiffness. Depending on the antiarthritic drug class, it is used for managing pain, reducing inflammation or acting as an immunosuppressant. These drugs are typically given orally, topically or through administration by injection. The choice of antiarthritic medication is often determined by the nature of arthritis, the severity of symptoms as well as other factors, such as the tolerability of side effects.

References

  1. 1 2 "Prednisolone Use During Pregnancy". Drugs. 16 January 2000. Archived from the original on 21 December 2016. Retrieved 9 March 2020.
  2. ↑ Pickup ME (1979). "Clinical pharmacokinetics of prednisone and prednisolone". Clinical Pharmacokinetics. 4 (2): 111–28. doi:10.2165/00003088-197904020-00004. PMID   378499. S2CID   12218704.
  3. ↑ Bergrem H, Grøttum P, Rugstad HE (1983). "Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration". European Journal of Clinical Pharmacology. 24 (3): 415–9. doi:10.1007/BF00610064. PMID   6861855. S2CID   33189235.
  4. ↑ Bashar T, Apu MN, Mostaid MS, Islam MS, Hasnat A (2018). "Pharmacokinetics and Bioavailability Study of a Prednisolone Tablet as a Single Oral Dose in Bangladeshi Healthy Volunteers". Dose-response. 16 (3). doi:10.1177/1559325818783932. PMC   6073839 . PMID   30083083.
  5. 1 2 Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization. pp. 53–54. hdl:10665/44053. ISBN   978-924154765-9.
  6. 1 2 3 4 5 "Prednisolone". The American Society of Health-System Pharmacists. Archived from the original on 23 December 2016. Retrieved 8 December 2016.
  7. 1 2 3 4 5 "Orapred ODT- prednisolone sodium phosphate tablet, orally disintegrating". DailyMed. 11 September 2019. Archived from the original on 12 May 2021. Retrieved 9 March 2020.
  8. 1 2 3 "Omnipred- prednisolone acetate suspension". DailyMed. 9 September 2019. Archived from the original on 13 May 2021. Retrieved 9 March 2020.
  9. ↑ "Pevanti 10mg Tablets – Summary of Product Characteristics (SPC) – (eMC)". Medicines. UK. 1 December 2014. Archived from the original on 20 December 2016. Retrieved 13 December 2016.
  10. 1 2 Kim KW, Roh JK, Wee HJ, Kim C (2016). Cancer Drug Discovery: Science and History. Springer. p. 169. ISBN   978-940240844-7. Archived from the original on 10 September 2017.
  11. ↑ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl: 10665/371090 . WHO/MHP/HPS/EML/2023.02.
  12. ↑ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  13. ↑ "Prednisolone Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
  14. 1 2 3 4 5 "Prednisolone phosphate". go.drugbank.com. Archived from the original on 25 February 2023. Retrieved 16 March 2022.
  15. ↑ Schwiebert LM, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP, Schwiebert LA (January 1996). "Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions". The Journal of Allergy and Clinical Immunology. 97 (1 Pt 2): 143–52. doi: 10.1016/s0091-6749(96)80214-4 . PMID   8568145. S2CID   27261595.
  16. ↑ Lee SH (November 2015). "Mechanisms of Glucocorticoid Action in Chronic Rhinosinusitis". Allergy, Asthma & Immunology Research. 7 (6): 534–7. doi:10.4168/aair.2015.7.6.534. PMC   4605925 . PMID   26333699.
  17. ↑ Czock D, Keller F, Rasche FM, Häussler U (2005). "Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids". Clinical Pharmacokinetics. 44 (1): 61–98. doi:10.2165/00003088-200544010-00003. PMID   15634032. S2CID   24458998.
  18. ↑ Fiel SB, Vincken W (June 2006). "Systemic corticosteroid therapy for acute asthma exacerbations". The Journal of Asthma. 43 (5): 321–31. doi:10.1080/02770900600567163. PMID   16801135. S2CID   24656857.
  19. 1 2 Spickett G (2014). "Urticaria and angioedema". J R Coll Physicians Edinb. 44 (1): 50–4. doi: 10.4997/JRCPE.2014.112 (inactive 1 December 2024). PMID   24995449.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
  20. ↑ Thrower BW (January 2009). "Relapse management in multiple sclerosis". The Neurologist. 15 (1): 1–5. doi:10.1097/NRL.0b013e31817acf1a. PMID   19131851. S2CID   10687818.
  21. ↑ Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, Zoumakis E, Tzortzatou-Stathopoulou F (December 2009). "Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression". Leukemia Research. 33 (12): 1684–95. doi:10.1016/j.leukres.2009.04.018. PMID   19450877.
  22. ↑ Miura M, Tamame T, Naganuma T, Chinen S, Matsuoka M, Ohki H (October 2011). "Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy". Paediatrics & Child Health. 16 (8): 479–84. doi:10.1093/pch/16.8.479. PMC   3202387 . PMID   23024586.
  23. ↑ "Prednisolone 5mg Tablets - Summary of Product Characteristics (SmPC) - (emc)". Medicines. UK. Archived from the original on 27 November 2022. Retrieved 27 November 2022.
  24. ↑ Gera K, Gupta N, Ahuja A, Shah A (April 2014). "Acute alveolar sarcoidosis presenting with hypoxaemic respiratory failure". BMJ Case Reports. 2014: bcr2013202247. doi:10.1136/bcr-2013-202247. PMC   4024548 . PMID   24789154.
  25. 1 2 "Millipred- prednisolone tablet". DailyMed. NIH. 8 April 2019. Archived from the original on 9 March 2020. Retrieved 9 March 2020.
  26. ↑ Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (October 2011). "[Drug interactions and immunosuppression in organ transplant recipients]". Tidsskrift for den Norske Laegeforening. 131 (20): 2000–3. doi: 10.4045/tidsskr.11.0138 . PMID   22016125.
  27. ↑ Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH (February 2014). "Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency". Journal of Internal Medicine. 275 (2): 104–15. doi: 10.1111/joim.12162 . PMID   24330030. S2CID   206117017.
  28. ↑ AMA Department of Drugs: AMA Drug Evaluations (6th ed.). Chicago, IL: American Medical Association. 1986.
  29. 1 2 3 4 5 6 7 8 9 10 "Prednisolone (ophthalmic): Drug information".
  30. 1 2 "Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e > Ocular Pharmacy". AccessPharmacy. Archived from the original on 16 March 2022. Retrieved 16 March 2022.
  31. 1 2 "Prednisolone (Ophthalmic Route) Side Effects". Mayo Clinic. Archived from the original on 25 February 2023. Retrieved 16 March 2022.
  32. ↑ "Common and Rare Side Effects for prednisolone acetate ophthalmic (eye)". www.webmd.com. Archived from the original on 21 May 2022. Retrieved 16 March 2022.
  33. 1 2 3 "Pred Forte- prednisolone acetate suspension/ drops". DailyMed. 19 July 2019. Archived from the original on 9 March 2020. Retrieved 9 March 2020.
  34. 1 2 "Pred Mild- prednisolone acetate suspension/ drops". DailyMed. 19 July 2019. Archived from the original on 9 March 2020. Retrieved 9 March 2020.
  35. ↑ Herretes S, Wang X, Reyes JM (October 2014). "Topical corticosteroids as adjunctive therapy for bacterial keratitis". The Cochrane Database of Systematic Reviews. 2014 (10): CD005430. doi:10.1002/14651858.CD005430.pub3. PMC   4269217 . PMID   25321340.
  36. ↑ Arslan N, Tepe D, Taştan E, Demirci M, Caydere M, Ustun H, Oguz H (November 2012). "Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis". European Archives of Oto-Rhino-Laryngology. 269 (11): 2335–2341. doi:10.1007/s00405-011-1889-z. PMID   22197890. S2CID   23472925.
  37. ↑ Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, et al. (April 2020). "Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis". Ophthalmology. 127 (4S): S5 –S18. doi:10.1016/j.ophtha.2020.01.037. PMID   32200827. S2CID   214616647.
  38. ↑ Gayam K, Ramulu PY, Rengaraj V, Srinivasan K (29 February 2020). "Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial". Ophthalmology. Glaucoma. 3 (3): 174–180. doi:10.1016/j.ogla.2020.02.006. PMID   32672612. S2CID   90234022.
  39. 1 2 "BNF: Prednisolone, Medicine Forms". Medicines Complete. Archived from the original on 16 March 2022. Retrieved 14 April 2022.
  40. 1 2 "Flo-Pred- prednisolone acetate suspension". DailyMed. 28 February 2019. Archived from the original on 9 May 2021. Retrieved 9 March 2020.
  41. 1 2 3 4 "Pediapred- prednisolone sodium phosphate solution". DailyMed. 29 January 2020. Archived from the original on 9 May 2021. Retrieved 9 March 2020.
  42. ↑ "Prednisolone (Oral Route)". Mayo Clinic. Retrieved 1 August 2023.
  43. ↑ ReMine SG, McIlrath DC (1980). "Bowel perforation in steroid-treated patients". Annals of Surgery. 192 (4): 581–6. doi:10.1097/00000658-198010000-00016. PMC   1347010 . PMID   7425698.
  44. ↑ Cervin A, Andersson M (September 1998). "Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes". Rhinology. 36 (3): 128–32. PMID   9830677.
  45. ↑ Goldstein BG, Goldstein AO (13 September 2022). Dellavalle RP, Levy ML, Corona R (eds.). "Topical corticosteroids: Use and adverse effects".
  46. ↑ Stahn C, Löwenberg M, Hommes DW, Buttgereit F (September 2007). "Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists" (PDF). Molecular and Cellular Endocrinology. 275 (1–2): 71–78. doi:10.1016/j.mce.2007.05.019. PMID   17630118. S2CID   4121936. Archived (PDF) from the original on 28 September 2020. Retrieved 27 June 2019.
  47. 1 2 Schijvens AM, Ter Heine R, de Wildt SN, Schreuder MF (March 2019). "Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome". Pediatric Nephrology. 34 (3): 389–403. doi:10.1007/s00467-018-3929-z. PMC   6349812 . PMID   29549463.
  48. ↑ "Prednisolone acetate". go.drugbank.com. Archived from the original on 25 February 2023. Retrieved 16 March 2022.
  49. ↑ "What's the Difference Between Prednisolone and Prednisone?". Archived from the original on 10 October 2022. Retrieved 27 November 2022.
  50. ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1011–1012. ISBN   978-1-4757-2085-3. Archived from the original on 10 September 2017.
  51. ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 869–. ISBN   978-3-88763-075-1. Archived from the original on 10 September 2017.
  52. ↑ "Prednisolone (Ophthalmic Route)". Mayo Foundation for Medical Education and Research.
  53. ↑ "Prednisolone Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD". www.webmd.com. Retrieved 29 February 2024.
  54. 1 2 3 4 5 "Prednisolone ophthalmic Use During Pregnancy". Drugs.com. Archived from the original on 25 February 2023. Retrieved 16 March 2022.
  55. ↑ "Prednisolone: Uses, Dosage, Side Effects, Warnings". Drugs.com. 6 July 2022.
  56. ↑ "Prohibited List" (PDF). World Anti-Doping Agency. January 2020. Archived (PDF) from the original on 9 March 2020.
  57. 1 2 3 4 "PrednisoLONE Acetate Ophthalmic Suspension". www.vetrxdirect.com. Archived from the original on 25 February 2023. Retrieved 16 March 2022.
  58. 1 2 3 "Prednisolone Acetate Ophthalmic for Veterinary Use". www.wedgewoodpharmacy.com. Archived from the original on 4 July 2022. Retrieved 16 March 2022.
  59. ↑ Gollakner R. "Prednisolone/Prednisone". VCA Hospitals. Archived from the original on 21 June 2021. Retrieved 3 July 2021.
  60. ↑ Videla R, Sommardahl C, Smith J, Schaefer DM, Cox S (2021). "Pharmacokinetics of Orally Administered Prednisolone in Alpacas". Frontiers in Veterinary Science. 8: 745890. doi: 10.3389/fvets.2021.745890 . PMC   8569471 . PMID   34746285.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.